Serum VEGF--as a prognostic factor of atherosclerosis

Kuriko Kimura1, Teruto Hashiguchi, Takahisa Deguchi

  • 1Department of Neurology and Geriatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Japan.

Atherosclerosis
|December 5, 2006
PubMed

Insights

Serum vascular endothelial growth factor (VEGF) levels may indicate atherosclerosis risk, particularly in men. Higher VEGF concentrations correlated with factors like platelet count and body fat, suggesting a link to disease progression.

Area of Science:

  • Cardiovascular Biology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Vascular Endothelial Growth Factor (VEGF) plays a role in atherosclerosis pathogenesis.
  • Serum VEGF concentration is being investigated as a potential biomarker for atherosclerosis.

Purpose of the Study:

  • To evaluate the utility of serum VEGF concentration as an index for atherosclerosis.
  • To analyze the relationship between serum VEGF levels and various physiological parameters in adults.

Main Methods:

  • Serum VEGF concentrations were analyzed in 443 adult participants during medical checkups.
  • Correlations were examined between serum VEGF levels and factors including platelet count, body fat percentage, leukocyte count, and HDL-cholesterol.
  • Multiple regression analysis was performed to identify key predictors of serum VEGF concentration in men.

Main Results:

  • Mean serum VEGF was significantly higher in men (229 pg/ml) than women (182 pg/ml).
  • Platelet count showed a positive correlation with serum VEGF in both genders.
  • In men, serum VEGF correlated with platelet count, body fat percentage, leukocyte count, and HDL-cholesterol (negatively).
  • Male smokers exhibited higher serum VEGF levels compared to non-smokers.

Conclusions:

  • Serum VEGF concentration may be closely linked to atherosclerosis acceleration, especially in men.
  • Factors such as platelet count, body fat, leukocyte count, and HDL-cholesterol influence serum VEGF levels in men.
  • Smoking status significantly impacts VEGF levels and related biomarkers in men.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...